The Legal Intelligencer | News
By Max Mitchell | April 4, 2019
A three-judge Superior Court panel determined that ties between Ethicon, a J&J subsidiary that is the main defendant in the pelvic mesh litigation in Philadelphia, and Secant, a Pennsylvania-based company that was involved in manufacturing the mesh product at issue, were sufficient to establish jurisdiction in the Keystone State.
The Legal Intelligencer | Commentary
By Matthew A. Pearson, Angie Verrecchio and Jason Weil | March 29, 2019
For pharmaceutical inventions, which usually undergo a lengthy FDA approval process before any drug can be sold, the most valuable portion of patent term is at the end of the patent's life, after FDA approval.
The Legal Intelligencer | Commentary
By Chipo M. Jolibois and Shahnam Sharareh | March 28, 2019
In this article, we briefly review the doctrine of inherency, in the context of an obviousness rejection, as a bar to patentability.
The Legal Intelligencer | Commentary
By James Gould | March 28, 2019
Thanks to recent decisions by the U.S. Court of Appeals for the Federal Circuit (CAFC), we have clarity that both requirements must be met to appeal an adverse final written decision issued during that IPR, and we also have some guidance as to how these requirements will be determined in such cases.
The Legal Intelligencer | News
By Max Mitchell | March 25, 2019
All of the filed cases are based on claims that Bayer and Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, failed to adequately warn that the drug could cause dangerous bleeding episodes.
The Legal Intelligencer | Commentary
By Steve Schain | March 25, 2019
Envision managing the risk of a volatile, staggeringly lucrative, 100-percent federally legal enterprise? Toss in ridiculously inconsistent federal, state and local regulations, insanely evolving technologies and efficiencies and an industrywide disinclination to ever "play by the rules."
The Legal Intelligencer | News
By Max Mitchell | March 22, 2019
The judge overseeing Philadelphia's Complex Litigation Center declined to grant a motion by J&J subsidiary Ethicon, which had requested that Powell be barred from handling pelvic mesh trials because his mother is pursuing a lawsuit against another J&J subsidiary over the blood thinner Xarelto.
The Legal Intelligencer | News
By Max Mitchell | March 19, 2019
UFCW Local 1500 Welfare Fund, which is the largest union of grocery store workers in New York state, filed the proposed class action lawsuit against AbbVie and numerous other companies Monday, contending that AbbVie abused the patent process and colluded with other drug companies to improperly stave off competition for Humira in the U.S. market.
The Legal Intelligencer | Commentary
By Nicole D. Galli | March 19, 2019
These top three areas of risk include: the absence of an IP strategy; failure to protect trade secrets; and relying on business people or lawyers who are not IP litigators to send out cease and desist letters.
By Max Mitchell | March 14, 2019
The high court recently denied a motion that Ethicon, a subsidiary of J&J, filed seeking to have the justices use their King's Bench jurisdiction to remove Judge Kenneth Powell from hearing the case McFarland v. Ethicon, which is currently ongoing.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Seeking a compassionate and experienced estate administration attorney for growing boutique estate planning and elder law practice. Huge eq...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS